Consolidative Radiotherapy Combined With Camrelizumab and Chemotherapy for Oligometastatic Nasopharyngeal Carcinoma
Clinical trial NCT05128201 · UNKNOWN
Trial details
- NCT number
- NCT05128201
- Sponsor
- Jiangxi Provincial Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2025-05-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.